Follow
Mathieu Gigoux
Mathieu Gigoux
Verified email at mskcc.org - Homepage
Title
Cited by
Cited by
Year
Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers
T Gruosso, M Gigoux, VSK Manem, N Bertos, D Zuo, I Perlitch, SMI Saleh, ...
The Journal of clinical investigation 129 (4), 1785-1800, 2019
3142019
Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase
M Gigoux, J Shang, Y Pak, M Xu, J Choe, TW Mak, WK Suh
Proceedings of the National Academy of Sciences 106 (48), 20371-20376, 2009
2722009
Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
LF Campesato, S Budhu, J Tchaicha, CH Weng, M Gigoux, IJ Cohen, ...
Nature communications 11 (1), 4011, 2020
2272020
Pharmacologic modulation of RNA splicing enhances anti-tumor immunity
SX Lu, E De Neef, JD Thomas, E Sabio, B Rousseau, M Gigoux, DA Knorr, ...
Cell 184 (15), 4032-4047. e31, 2021
1492021
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
D Zamarin, JM Ricca, S Sadekova, A Oseledchyk, Y Yu, ...
The Journal of clinical investigation 128 (4), 1413-1428, 2018
1422018
Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
M Łuksza, ZM Sethna, LA Rojas, J Lihm, B Bravi, Y Elhanati, K Soares, ...
Nature 606 (7913), 389-395, 2022
952022
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants
D Hirschhorn, S Budhu, L Kraehenbuehl, M Gigoux, D Schröder, A Chow, ...
Cell 186 (7), 1432-1447. e17, 2023
562023
Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer
AZ Lai, S Cory, H Zhao, M Gigoux, A Monast, MC Guiot, S Huang, ...
Science signaling 7 (322), ra38-ra38, 2014
472014
Anti-chlamydial Th17 responses are controlled by the inducible costimulator partially through phosphoinositide 3-kinase signaling
X Gao, M Gigoux, J Yang, J Leconte, X Yang, WK Suh
PloS one 7 (12), e52657, 2012
462012
Inducible costimulator facilitates T-dependent B cell activation by augmenting IL-4 translation
M Gigoux, A Lovato, J Leconte, J Leung, N Sonenberg, WK Suh
Molecular immunology 59 (1), 46-54, 2014
412014
Miz-1 regulates translation of Trp53 via ribosomal protein L22 in cells undergoing V (D) J recombination
M Rashkovan, C Vadnais, J Ross, M Gigoux, WK Suh, W Gu, C Kosan, ...
Proceedings of the National Academy of Sciences 111 (50), E5411-E5419, 2014
352014
Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus
A Oseledchyk, JM Ricca, M Gigoux, B Ko, G Redelman-Sidi, T Walther, ...
Oncotarget 9 (47), 28702, 2018
312018
Phosphatidylinositol 3-kinase–independent signaling pathways contribute to ICOS-mediated T cell costimulation in acute graft-versus-host disease in mice
J Li, J Heinrichs, J Leconte, K Haarberg, K Semple, C Liu, M Gigoux, ...
The Journal of Immunology 191 (1), 200-207, 2013
302013
Identification of interacting stromal axes in triple-negative breast cancer
SMI Saleh, N Bertos, T Gruosso, M Gigoux, M Souleimanova, H Zhao, ...
Cancer research 77 (17), 4673-4683, 2017
292017
Targeting phosphatidylserine enhances the anti-tumor response to tumor-directed radiation therapy in a preclinical model of melanoma
S Budhu, R Giese, A Gupta, K Fitzgerald, R Zappasodi, S Schad, ...
Cell reports 34 (2), 2021
262021
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade
JA Pai, MD Hellmann, JL Sauter, M Mattar, H Rizvi, HJ Woo, N Shah, ...
Cancer Cell 41 (4), 776-790. e7, 2023
192023
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions
SE Schad, A Chow, L Mangarin, H Pan, J Zhang, N Ceglia, JX Caushi, ...
Journal of Experimental Medicine 219 (6), e20212169, 2022
132022
Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer
S Lebdai, M Gigoux, R Alvim, A Somma, K Nagar, AR Azzouzi, ...
Oncoimmunology 8 (6), e1581528, 2019
132019
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
M Gigoux, MO Holmström, R Zappasodi, JJ Park, S Pourpe, CC Bozkus, ...
Science translational medicine 14 (649), eaba4380, 2022
112022
Distinct immune microenvironments stratify triple-negative breast cancer and predict outcome
T Gruosso, M Gigoux, N Bertos, VSK Manem, MC Guiot, L Buisseret, ...
Annals of Oncology 28, i16, 2017
52017
The system can't perform the operation now. Try again later.
Articles 1–20